Is it time to change surgery for early-stage low-risk cervical cancer to simple hysterectomy?
J Gynecol Oncol. 2024 Jan 23. doi: 10.3802/jgo.2024.35.e47. Online ahead of print.NO ABSTRACTPMID:38425138 | DOI:10.3802/jgo.2024.35.e47 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 1, 2024 Category: OBGYN Authors: Jeong-Yeol Park Source Type: research
Simple hysterectomy < em > SHAPE-ing < /em > up to be the treatment of choice for early cervical cancer under 2 cm
J Gynecol Oncol. 2024 Jan 12. doi: 10.3802/jgo.2024.35.e49. Online ahead of print.NO ABSTRACTPMID:38425139 | DOI:10.3802/jgo.2024.35.e49 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 1, 2024 Category: OBGYN Authors: Anouk Benseler Allan Covens Source Type: research
Comparison of outcomes of laparotomic and minimally invasive radical hysterectomy in women with early-stage cervical cancer
CONCLUSION: After PSM, MISRH is associated with nonsignificantly lower OS but a significantly higher risk of intraoperative urological complications than LRH.PMID:38425140 | DOI:10.3802/jgo.2024.35.e60 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 1, 2024 Category: OBGYN Authors: Shu-Han Chang Kuan-Gen Huang Lan-Yan Yang Yu-Bin Pan Chyong-Huey Lai Hung-Hsueh Chou Source Type: research
The efficacy of the levonorgestrel intrauterine system versus oral megestrol acetate in treating atypical endometrial hyperplasia: a superior randomized controlled trial
CONCLUSION: Compared to MA, the LNG-IUS was more efficacious in treating AEH in women who declined hysterectomy, especially those with moderate/severe obesity, with fewer adverse effects and less weight gain. Extending therapy to 12 months for persistent cases would improve regression rates with reasonable safety. Alternate hysteroscopic and office sampling seemed convenient for follow-up.TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04385667.PMID:38425141 | DOI:10.3802/jgo.2024.35.e62 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 1, 2024 Category: OBGYN Authors: Amr A Alnemr Ola A Harb Hytham Atia Source Type: research
Is it time to change surgery for early-stage low-risk cervical cancer to simple hysterectomy?
J Gynecol Oncol. 2024 Jan 23. doi: 10.3802/jgo.2024.35.e47. Online ahead of print.NO ABSTRACTPMID:38425138 | DOI:10.3802/jgo.2024.35.e47 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 1, 2024 Category: OBGYN Authors: Jeong-Yeol Park Source Type: research
Simple hysterectomy < em > SHAPE-ing < /em > up to be the treatment of choice for early cervical cancer under 2 cm
J Gynecol Oncol. 2024 Jan 12. doi: 10.3802/jgo.2024.35.e49. Online ahead of print.NO ABSTRACTPMID:38425139 | DOI:10.3802/jgo.2024.35.e49 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 1, 2024 Category: OBGYN Authors: Anouk Benseler Allan Covens Source Type: research
Comparison of outcomes of laparotomic and minimally invasive radical hysterectomy in women with early-stage cervical cancer
CONCLUSION: After PSM, MISRH is associated with nonsignificantly lower OS but a significantly higher risk of intraoperative urological complications than LRH.PMID:38425140 | DOI:10.3802/jgo.2024.35.e60 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 1, 2024 Category: OBGYN Authors: Shu-Han Chang Kuan-Gen Huang Lan-Yan Yang Yu-Bin Pan Chyong-Huey Lai Hung-Hsueh Chou Source Type: research
The efficacy of the levonorgestrel intrauterine system versus oral megestrol acetate in treating atypical endometrial hyperplasia: a superior randomized controlled trial
CONCLUSION: Compared to MA, the LNG-IUS was more efficacious in treating AEH in women who declined hysterectomy, especially those with moderate/severe obesity, with fewer adverse effects and less weight gain. Extending therapy to 12 months for persistent cases would improve regression rates with reasonable safety. Alternate hysteroscopic and office sampling seemed convenient for follow-up.TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04385667.PMID:38425141 | DOI:10.3802/jgo.2024.35.e62 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 1, 2024 Category: OBGYN Authors: Amr A Alnemr Ola A Harb Hytham Atia Source Type: research
Is it time to change surgery for early-stage low-risk cervical cancer to simple hysterectomy?
J Gynecol Oncol. 2024 Jan 23. doi: 10.3802/jgo.2024.35.e47. Online ahead of print.NO ABSTRACTPMID:38425138 | DOI:10.3802/jgo.2024.35.e47 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 1, 2024 Category: OBGYN Authors: Jeong-Yeol Park Source Type: research
Simple hysterectomy < em > SHAPE-ing < /em > up to be the treatment of choice for early cervical cancer under 2 cm
J Gynecol Oncol. 2024 Jan 12. doi: 10.3802/jgo.2024.35.e49. Online ahead of print.NO ABSTRACTPMID:38425139 | DOI:10.3802/jgo.2024.35.e49 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 1, 2024 Category: OBGYN Authors: Anouk Benseler Allan Covens Source Type: research
Comparison of outcomes of laparotomic and minimally invasive radical hysterectomy in women with early-stage cervical cancer
CONCLUSION: After PSM, MISRH is associated with nonsignificantly lower OS but a significantly higher risk of intraoperative urological complications than LRH.PMID:38425140 | DOI:10.3802/jgo.2024.35.e60 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 1, 2024 Category: OBGYN Authors: Shu-Han Chang Kuan-Gen Huang Lan-Yan Yang Yu-Bin Pan Chyong-Huey Lai Hung-Hsueh Chou Source Type: research
The efficacy of the levonorgestrel intrauterine system versus oral megestrol acetate in treating atypical endometrial hyperplasia: a superior randomized controlled trial
CONCLUSION: Compared to MA, the LNG-IUS was more efficacious in treating AEH in women who declined hysterectomy, especially those with moderate/severe obesity, with fewer adverse effects and less weight gain. Extending therapy to 12 months for persistent cases would improve regression rates with reasonable safety. Alternate hysteroscopic and office sampling seemed convenient for follow-up.TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04385667.PMID:38425141 | DOI:10.3802/jgo.2024.35.e62 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 1, 2024 Category: OBGYN Authors: Amr A Alnemr Ola A Harb Hytham Atia Source Type: research
Is it time to change surgery for early-stage low-risk cervical cancer to simple hysterectomy?
J Gynecol Oncol. 2024 Jan 23. doi: 10.3802/jgo.2024.35.e47. Online ahead of print.NO ABSTRACTPMID:38425138 | DOI:10.3802/jgo.2024.35.e47 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 1, 2024 Category: OBGYN Authors: Jeong-Yeol Park Source Type: research
Simple hysterectomy < em > SHAPE-ing < /em > up to be the treatment of choice for early cervical cancer under 2 cm
J Gynecol Oncol. 2024 Jan 12. doi: 10.3802/jgo.2024.35.e49. Online ahead of print.NO ABSTRACTPMID:38425139 | DOI:10.3802/jgo.2024.35.e49 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 1, 2024 Category: OBGYN Authors: Anouk Benseler Allan Covens Source Type: research
Comparison of outcomes of laparotomic and minimally invasive radical hysterectomy in women with early-stage cervical cancer
CONCLUSION: After PSM, MISRH is associated with nonsignificantly lower OS but a significantly higher risk of intraoperative urological complications than LRH.PMID:38425140 | DOI:10.3802/jgo.2024.35.e60 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 1, 2024 Category: OBGYN Authors: Shu-Han Chang Kuan-Gen Huang Lan-Yan Yang Yu-Bin Pan Chyong-Huey Lai Hung-Hsueh Chou Source Type: research
